期刊文献+

腺病毒介导的shRNA沉默hTERT基因表达对鼻咽癌细胞增殖和凋亡的影响 被引量:2

Effect of Adv Vector-mediated shRNA Targeting hTERT on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells
下载PDF
导出
摘要 目的探讨靶向人端粒酶反转录酶(hTERT)的短发夹RNA(shRNA)对人鼻咽癌细胞株CNE-2 hTERT表达的影响,及其对鼻咽癌细胞增殖和凋亡的效应。方法构建表达绿色荧光蛋白(EGFP)基因和靶向hTERT基因短发夹RNA的重组腺病毒质粒,观察其对鼻咽癌细胞株(CNE-2)的转染效果,RT-PCR检测hTERT mRNA表达水平,Western blot检测hTERT蛋白表达水平,CCK-8法检测细胞增殖活性,流式细胞仪检测细胞凋亡状况。结果 Adv-EGFP-shTERT重组腺病毒质粒转染率可达90%以上,成功转染CNE-2细胞24 h后,hTERT mRNA的表达水平显著下降,转染48 h后,hTERT蛋白表达明显下调,细胞增殖活性受到显著抑制,细胞凋亡率可达23.0%。结论腺病毒载体介导靶向hTERT基因的RNA干扰,能显著抑制端粒酶反转录酶表达,进而抑制端粒酶活性,抑制CNE-2细胞增殖并诱导其凋亡,为鼻咽癌的基因治疗研究提供了理论基础。 Objective To evaluate the effect of targeting hTERT gene on the proliferation and apoptosis of CNE-2 cells by applying RNA interference to restrain the expression of hTERT in nasopharyngeal carcinoma CNE-2 cells.Methods Recombinant adenovirus vectors expressing EGFP and human TERT shRNA were construted and transfected in human nasopharyngeal carcinoma CNE-2 cells.The expression levels of hTERT mRNA and protein were detected respectively by RT-PCR and Western blot method.Cell proliferation was determined by CCK-8 assay and cell apoptosis was observed by FCM(Flow cytometric).Results The transfection rate of Adv-EGFP-shTERT recombinant adenovirus plasmid in CNE-2 cell line was more than 90 %.The expression levels of the hTERT mRNA and protein were dramatic declining respectively at 24h and 48h after transfection.Cell proliferation activity was significantly inhibited and the cell apoptosis reached 23.0%.Conclusion Adv vector-mediated RNAi targeting hTERT can inhibit the activity of telomerase reverse transcriptase by down-regulating the expression of the hTERT mRNA and its protein significantly,therefore can inhibit the growth of the cells and induce their apoptosis.Future application of RNAi to the gene therapy of nasopharyngeal carcinoma might be expected.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第12期1351-1355,共5页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金资助项目(30872851)
关键词 RNA干扰 腺病毒载体 HTERT基因 NPC细胞 RNA interference Viral vectors hTERT genes NPC cells
  • 相关文献

参考文献10

  • 1Tollefsbol TO,Andrews LG.Mechanisms for telomerase gene control in aging cells and tumorigenesis[J].Med Hypotheses,2001,56(6):630-637.
  • 2李刚,谭晓虹.RNA干扰survivin对口腔表皮样癌细胞株KB生长的抑制作用[J].肿瘤防治研究,2011,38(3):257-260. 被引量:3
  • 3Brummelkamp TR,Bemards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550-553.
  • 4陈晨,陶泽璋,陈始明,肖伯奎,王燕,陈伟.人EGFP-TERT-VEGF-Bcl-xl shRNA重组腺病毒的构建与鉴定[J].华中医学杂志,2009,33(3):117-119. 被引量:1
  • 5Stewart SA,Weinberg RA.Telomerase and human tumorigenesis [J].Semin Cancer Biol,2000,10 (6):399-406.
  • 6Stewart SA,Hahn WC,OConnor BF,et al.Telomerase contributes to tumorigenesis by a telomere length-independent mechanism[J].Proc Natl Acad Sci U S A,2002,99(20):12606-12611.
  • 7Kim NW,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cella and cancer[J].Science,1994,266(5193):2011-2015.
  • 8Neidle S,Parkinson G.Telomere maintenance as a target for anticancer drug discovery[J].Nat Rev Drug Discov,2002,1(5):383-393.
  • 9Biroccio A,Leonetti C.Telomerase as a new target for the treatment of hormone-refractory prostate cancer[J].Endocr Relat Cancer,2004,11(3):407-421.
  • 10de Fougerolles AR. Delivery vehicles for small interfering RNA in vivo[J].Hum Gene Ther,2008,19(2): 125-132.

二级参考文献16

  • 1Xue, Xin-Bo,Chen, Kun,Wang, Cong-Jun,Zheng, Jian-Wei,Yu, Yuan,Peng, Zhi-Hai,Wu, Zai-De.Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B[J].Hepatobiliary & Pancreatic Diseases International,2008,7(5):509-514. 被引量:6
  • 2刘丹,陶泽璋,肖伯奎,陈始明,池花明.短发夹RNA沉默hTERT基因对人喉癌裸鼠移植瘤的生长抑制作用[J].癌症,2006,25(1):11-16. 被引量:12
  • 3Lodi G,Franchini R,Bez Cet al.Detection of survivin mRNAin healthy oral mucosa,oral leucoplakia and oral cancer. O-ral Dis . 2010
  • 4Marioni G,Bedogni A,Giacomelli Let al.Survivin expres-sion is significantly higher in pN+oral and oropharyngeal pri-mary squamous cell carcinomas than in pN0carcinomas. Acta Oto laryngologica . 2005
  • 5Aagaard L,Rossi JJ.RNAi therapeutics:principles,pros-pects and challenges. Advanced Drug Delivery Reviews . 2007
  • 6Altieri DC.Survivin,Cancer networks and pathway-directeddrug discovery. Nature Reviews Cancer . 2008
  • 7Youesaka K,Tamura K,Kurata Tet al.Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. International Journal of Cancer . 2006
  • 8EJ Dean,M Ranson,F Blackhall,SV Holt,C Dive.Novel therapeutic targets in lung cancer: inhibitor of apoptosis proteins from laboratory to clinic. Cancer Treatment Reviews . 2007
  • 9Kobayashi J,Torigoe T,Hirohashi Y, et a1.Comparative study on the immuneo-genicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients. Journal of Translational Medicine . 2009
  • 10Lo Muzio L,Farina A,Rubini C,et al.Survivin as prognostic fac-tor in squamous cell carcinoma of the oral cavity. Cancer Letters . 2005

共引文献2

同被引文献44

  • 1韩庆旺,樊燕蓉,傅更锋,刘新卷,徐根兴.RNA干扰对VEGF在人卵巢癌细胞中表达及细胞增殖的影响[J].第二军医大学学报,2005,26(9):992-996. 被引量:6
  • 2朱晓应,符伟军,洪宝发.端粒酶与肿瘤靶向治疗[J].国外医学(遗传学分册),2005,28(6):366-368. 被引量:7
  • 3丁昂,童赛雄,冯平,秦新裕.hTERT-siRNA抑制胆囊癌细胞端粒酶活性及增殖运动的研究[J].武汉大学学报(医学版),2006,27(3):287-290. 被引量:3
  • 4Burger AM. Highlights in experimental therapeutics [J]. Cancer Lett,2007,245 ( 1/2) : 11-21.
  • 5Bravaccini S, Casadio V, Amadori D, et al. The current role of telomerase in the diagnosis of bladder cancer [J]. Indian J Urol, 2009,25( 1 ) :40-46.
  • 6Kim NW, Patyszek MA, Prowse KR,et al. Specific association of human telomerase activity with immortal cells and cancer[ J ]. Sci- ence, 1994,266 (5193 ) :2011-2015.
  • 7Hiyama E, Kodama T, Shinbara K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors[ J]. Cancer Res,1997,57 (2) :326-331.
  • 8Liu J, Carmell MA, Rivas FV, et al. Argonaute 2 is the catalytic engine of mammalian RNAi [J]. Science, 2004, 305 ( 5689 ) : 1437-1d41.
  • 9Bae DS, Cho SB,Kim YJ,et al. Aberrant expression of cylin D1 is associated with poor prognosis in early stage cervical cancer of the uterus [ J ]. Gynecol Oneo1,2001,81 ( 3 ) : 341-347.
  • 10Irluang R, Zhao Z, Ma X, et al. Targeting of tumor radioiodine thera- py by expression of the sodium iodide symporter under control of the survivin promoter[J]. Cancer Gene Ther,2011,18 (2) : 144-152.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部